StockNews.com upgraded shares of MediWound (NASDAQ:MDWD – Free Report) from a sell rating to a hold rating in a report released on Wednesday morning. Other equities analysts have also recently issued research reports about the company. HC Wainwright raised their price target on MediWound from $23.00 to $26.00 and gave the company a buy rating […]
MediWound Ltd. (NASDAQ:MDWD – Get Free Report) shares crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $10.35 and traded as low as $8.92. MediWound shares last traded at $9.10, with a volume of 40,757 shares traded. Analyst Ratings Changes MDWD […]
HC Wainwright reaffirmed their buy rating on shares of MediWound (NASDAQ:MDWD – Free Report) in a report issued on Thursday, Benzinga reports. They currently have a $23.00 target price on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for MediWound’s FY2027 earnings at $1.14 EPS. Several other brokerages have also recently issued reports on […]
MediWound (NASDAQ:MDWD – Get Free Report) had its target price lowered by stock analysts at Oppenheimer from $63.00 to $36.00 in a research report issued on Thursday, MarketBeat.com reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. Oppenheimer’s price objective points to a potential upside of 300.89% from the stock’s current […]
MediWound Ltd. (NASDAQ:MDWD – Get Free Report) was the target of a significant growth in short interest in the month of July. As of July 15th, there was short interest totalling 45,700 shares, a growth of 6.5% from the June 30th total of 42,900 shares. Based on an average daily volume of 14,700 shares, the […]